# Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients

> **NCT00798070** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Karolinska University Hospital** · enrollment: 2017 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** dtEC→dtT
- **DRUG:** FEC→T

## Key facts

- **NCT ID:** NCT00798070
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2007-02
- **Primary completion:** 2016-04
- **Final completion:** 2028-01
- **Target enrollment:** 2017 (ACTUAL)
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798070, "Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00798070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*